Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL571 (19583RP, Actron, Actron ketoprofen, Alrheumat, Aneol, Axorid, Capisten, Fenoket 200, Hydratropic acid, m-benzoyl-, IDEA-033, Iso-k, Jomethid xl, Ketocid 200, Ketonal, Ketoprofen, Ketorin, Ketotard 200 xl, Ketovail, Ketozip 200 xl, Larafen, Larafen cr, Nexcede, NSC-758144, Orudis, Orudis 100, Orudis kt, Oruvail, Oruvail 100, Oruvail 150, Oruvail 200, Oruvail im, Powergel, R.P. 19,583, R.P. 19583, RP-19583, (rs)-ketoprofen, RU-4733, Sector, Tiloket, Tiloket cr, Valket 200 retard) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
GtoPdb | Inhibition of COX1 in human whole blood. | - | 6.48 | pIC50 | 330 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 4655-7 [PMID:18667313] |
ChEMBL | Inhibition of COX1 in human whole blood | B | 6.48 | pIC50 | 330 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 4655-4657 [PMID:18667313] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 7.85 | pIC50 | 14 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | In vitro inhibition of cyclooxygenase-1 via inhibition of TXB2 generation in the presence of 1 uM arachidonic acid in human platelet | F | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 533-537 [PMID:11844666] |
Cyclooxygenase-1 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2949] [UniProtKB: P05979] | ||||||||
ChEMBL | Inhibition of purified ovine COX1 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 6.1 | pIC50 | 800 | nM | IC50 | ACS Med Chem Lett (2014) 5: 983-988 [PMID:25221653] |
ChEMBL | Inhibition of Ovine COX-1 preincubated for 15 mins by fluorescence analysis | B | 7.17 | pIC50 | 67 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1086-1090 [PMID:26487917] |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of human recombinant COX2 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 5.42 | pIC50 | 3800 | nM | IC50 | ACS Med Chem Lett (2014) 5: 983-988 [PMID:25221653] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | B | 6.11 | pIC50 | 785 | nM | IC50 | DrugMatrix in vitro pharmacology data |
GtoPdb | Inhibition of COX2 in human whole blood. | - | 6.16 | pIC50 | 690 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 4655-7 [PMID:18667313] |
ChEMBL | Inhibition of COX2 in human whole blood | B | 6.16 | pIC50 | 690 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 4655-4657 [PMID:18667313] |
ChEMBL | Inhibition of recombinant human COX-2 preincubated for 15 mins by fluorescence analysis | B | 7.21 | pIC50 | 61 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1086-1090 [PMID:26487917] |
ChEMBL | In vitro inhibition of PGE-2 generation by LPS-stimulated monocytes isolated from human blood. | F | 7.59 | pIC50 | 26 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 533-537 [PMID:11844666] |
Cyclooxygenase-2 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4102] [UniProtKB: P79208] | ||||||||
ChEMBL | Inhibition of ovine COX2 assessed as reduction in PGH2 production by enzyme immunoassay | B | 6.74 | pIC50 | 180 | nM | IC50 | Bioorg Med Chem (2018) 26: 4113-4126 [PMID:29980364] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis | B | 5 | pIC50 | >10000 | nM | IC50 | ACS Med Chem Lett (2015) 6: 1086-1090 [PMID:26487917] |
Organic anion transporter 1/Solute carrier family 22 member 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1641347] [GtoPdb: 1025] [UniProtKB: Q4U2R8] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of 6-Carboxyfluorescein uptake in OAT1-expressing CHO cells | F | 5.85 | pIC50 | 1400 | nM | IC50 | Anal Biochem (2000) 283: 49-55 [PMID:10929807] |
ChEMBL | TP_TRANSPORTER: inhibition of Adefovir uptake in OAT1-expressing CHO cells | F | 5.89 | pIC50 | 1300 | nM | IC50 | J Pharmacol Exp Ther (2000) 295: 10-15 [PMID:10991954] |
Organic anion transporter 1/Solute carrier family 22 member 6 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1777665] [GtoPdb: 1025] [UniProtKB: O35956] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of MTX uptake in Xenopus laevis oocytes | F | 6.3 | pIC50 | 500 | nM | IC50 | Eur J Pharmacol (2000) 409: 31-36 [PMID:11099697] |
Organic anion transporter 2/Solute carrier family 22 member 7 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073671] [GtoPdb: 1026] [UniProtKB: Q5RLM2] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of Salicylate uptake in Oat2-expressing LLC PK1 cells | F | 5.74 | pKi | 1840 | nM | Ki | Jpn Pharmacol Ther (2001) 29: S101-S104 |
SMCT1 in Human [GtoPdb: 922] [UniProtKB: Q8N695] | ||||||||
GtoPdb | - | - | 3.92 | pIC50 | 119000 | nM | IC50 | Pharm Res (2006) 23: 1209-16 [PMID:16729224] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]